These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 4077027)

  • 21. [Polyspecific immune reaction in the central nervous system in autoimmune diseases with CNS involvement].
    Graef IT; Henze T; Reiber H
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):587-91. PubMed ID: 7856266
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of the "regression" of diabetes insipidus after pituitary stalk lesions in rats.
    KOVACS K; DAVID MA; LASZLO FA
    Acta Med Acad Sci Hung; 1963; 19():95-108. PubMed ID: 14035167
    [No Abstract]   [Full Text] [Related]  

  • 24. [Diabetes insipidus and postpartum anterior hypophyseal insufficiency].
    Tordjeman N; Monnier JC; Vantyghem-Haudiquet MC; Bouthors-Ducloy AS; Vinatier D
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):549-56. PubMed ID: 8228021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Non-organ specific anticytoplasmic autoantibodies. Immunoserologic detection and diagnostic relevance].
    Blaschek MA
    Wien Med Wochenschr; 1987 Jul; 137(13):303-9. PubMed ID: 3307168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of vasopressin on memory in healthy probands and patients with central diabetes insipidus].
    László FA
    Z Gesamte Inn Med; 1983 Aug; 38(15):413-5. PubMed ID: 6636903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical analysis of magnocellular elements in rat hypothalamus: distribution and numbers of cells containing neurophysin, oxytocin, and vasopressin.
    Rhodes CH; Morrell JI; Pfaff DW
    J Comp Neurol; 1981 May; 198(1):45-64. PubMed ID: 7014660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An iatrogenic autoantibody: immunological responses to 'pituitary snuff' in patients with diabetes insipidus.
    Pepys J; Jenkins PA; Lachmann PJ; Mahon WE
    Clin Exp Immunol; 1966 Oct; 1(4):377-89. PubMed ID: 4961408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies and autoimmune diseases in young diabetics.
    Kontiainen S; Schlenzka A; Koskimies S; Rilva A; Mäenpää J
    Diabetes Res; 1990 Apr; 13(4):151-6. PubMed ID: 2134205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DI patient refractory to vasopressin and dDAVP: absence of antibodies to AVP and dDAVP and inactivating factor in blood serum.
    Slaninová J; Skopková J; Barth T; Lichardus B; Földes O
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):84-6. PubMed ID: 570558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interdisciplinary Forum on Autoimmune Disease Research: guidelines].
    Sinico RA;
    G Ital Nefrol; 2002; 19(2):212-24. PubMed ID: 14518478
    [No Abstract]   [Full Text] [Related]  

  • 32. sirt1-null mice develop an autoimmune-like condition.
    Sequeira J; Boily G; Bazinet S; Saliba S; He X; Jardine K; Kennedy C; Staines W; Rousseaux C; Mueller R; McBurney MW
    Exp Cell Res; 2008 Oct; 314(16):3069-74. PubMed ID: 18687325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes mellitus and vasopressin sensitive diabetes insipidus.
    Padrón RS; Amaro S; Licea M; Hung S; González J; Mateo de Acosta O
    Acta Diabetol Lat; 1980; 17(2):179-83. PubMed ID: 7445914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organ-specific autoantibodies in coeliac disease: do they represent an epiphenomenon or the expression of associated autoimmune disorders?
    Volta U; De Franceschi L; Molinaro N; Tetta C; Bianchi FB
    Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):18-21. PubMed ID: 9265573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A new synthetic analog of vasopressin, desamino-6 carba-(8-D-arginin)-vasopressin, active against diabetes insipidus refractory to vasopressin and adiuretin spofa (author's transl)].
    Schück O; Cort JH; Stríbrná J; Skopková J; Jost K
    Cas Lek Cesk; 1975 Feb; 114(6):172-5. PubMed ID: 1092463
    [No Abstract]   [Full Text] [Related]  

  • 36. [Possibilities and value of immunofluorescence in the diagnosis of endocrine diseases].
    Scherbaum WA; Bottazzo GF; Doniach D
    Z Gesamte Inn Med; 1983 Feb; 38(4):107-15. PubMed ID: 6344464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in the study of autoimmune endocrine diseases by the use of immunofluorescence.
    Bottazzo GF; Scherbaum WA; Hanafusa T
    Ann N Y Acad Sci; 1983; 420():275-80. PubMed ID: 6372595
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunoassay of plasma vasopressin in man.
    Robertson GL; Klein LA; Roth J; Gorden P
    Proc Natl Acad Sci U S A; 1970 Aug; 66(4):1298-305. PubMed ID: 5273455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation of anti-vasopressin antibodies using an IgA carrier. Application to radioimmunoassay.
    Rougon-Rapuzzi G; Millet YA; Delaage MA
    Biochimie; 1977; 59(11-12):939-42. PubMed ID: 564715
    [No Abstract]   [Full Text] [Related]  

  • 40. Specificities of autoantibodies in autoimmune receptor diseases.
    De Baets MH
    Immunol Res; 1988; 7(3):218-31. PubMed ID: 2848079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.